CSI Market
Sign In | Register

Edwards Lifesciences (EW) Annual Balance Sheets

Annual · GAAP · USD millions
Access EW quarterly Balance Sheets →
This page allows investors to track Edwards Lifesciences's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2,938.00
Short-term Investments, Total1,288.30
Cash & Short-term Investments4,226.00
Accounts receivable659.60
Other Receivables, Net, Current252.50
Inventories1,126.20
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other current assets339.30
Prepaid Expense, Current AS135.00
Total Current Assets6,738.90
Equipment/Property/Plant Net1,811.90
Goodwill net1,768.60
Intangible Assets1,128.20
Long-term investments278.60
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS0.00
Other Assets2,249.60
Operating Lease Right Of Use Asset102.70
Deferred Income Tax Assets Net1,138.10
Total Assets13,697.20
Liabilities
Accounts Payable, Current AC227.50
Other current liabilities1,586.20
Taxes Payable, Total0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities1,813.70
Long-term debt598.30
Total Long-term Debt598.30
Estimated Litigation Liability, Noncurrent LI0.00
Liability for Uncertain Tax Positions, Noncurrent LI502.70
Other longterm liabilities444.90
Operating Lease Liability Current24.50
Operating Lease Liability Noncurrent82.60
Total Liabilities3,359.60
Stockholders' Equity
Treasury Stock Common Value-7,091.70
Common Stock Value658.70
Treasury Stock Value0.00
Additional Paid In Capital Common Stock2,768.40
Retained Earnings / Accumulated Deficit14,240.50
Other Equity-234.20
Common Stockholder's Equity10,341.70
Non-controlling interests & other0.00
Total Stockholder's Equity10,337.60
Liabilities & Stockholder's Equity13,697.20
4 historic quarters locked

Sign in to unlock the full Edwards Lifesciences balance sheet history.

Sign In Create Free Account

About Edwards Lifesciences Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: ew-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001099800-26-000009

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License